Skip to content

Rak dojk: Nov test, ki odloči o kemoterapiji

June 4, 2026 · 13 min

Show notes

Komentira dr. Domen Ribnikar.

Kemoterapija je že desetletja skoraj samoumeven del zdravljenja raka dojk. Zdaj pa je velika mednarodna raziskava pokazala, da bi se ji lahko številne bolnice varno izognile. Z novim genomskim testom lahko namreč zdravnice in zdravniki zdaj natančneje določijo, kateri bolnici kemoterapija koristi in kateri ne. Kaj ta preboj pomeni za prihodnost zdravljenja raka dojk? Kaj pomeni za kakovost življenja bolnic in tudi bolnikov? Z nami bo specialist internistične onkologije doc. dr. Domen Ribnikar z Onkološkega inštituta v Ljubljani.

Originalni članek v Guardianu TUKAJ

Foto: Domen Ribnikar/ Prvi

All episodes of Radiosfera

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.